Connect with us

Business

Mydecine Innovations Brings Onboard Ethica CRO As A Research Contract Partner For Phase 2A PTSD Clinical Trials

Published

on

Mydecine Innovations Group Inc (OTCMKTS:MYCO) looks forward to starting its Phase 2A PTSD clinical trials and sees ethica CRO (“ethica CRO”) as an ideal partner. After considering its excellent work towards introducing a new ethical dimension to clinical research, the business giant has chosen the partner.

CRO’s accreditations

The other thing that makes the partner ideal is that it became the first CRO to receive accreditation as a significant player in a human research protection program conducted back in 2006. Some people would also see the CRO getting accreditation from about three accrediting bodies as a significant achievement and qualification for the new partnership.

The CEO of Mydecine Innovations Group, Josh Bartch, applauded the move to collaborate with such a top-class partner. He hopes that the CRO’s outstanding expertise in managing clinical studies will be a great addition to their success in the upcoming Phase 2A PTSD clinical trials.

The official sees the move to bring onboard the new partner to show their outstanding preparations towards discovering how the brain reacts to psychedelics. The parties will also be looking to establish what a psychedelic experience could cause in biological underpinnings.

Mydecine wants to push its clinical development to the pinnacle, and it will be counting on its partner’s unparalleled experience in wide-ranging trials. Ethica CRO is known for its deep clinical expertise and will help a lot with the trial preparations.

Jensen’s perspective

The Managing Director of ethica CRO Murray Jensen is happy about the impressive mental health treatment changes. He terms Psychedelics and psychedelic-assisted therapies as some of the game-changers as they continue to progress with their innovation drive.

Mydecine is pleased to announce its partnership with Microdose Psychedelic Insights, a move that will see the two focus on unveiling a free, live webinar series. Reports show that the series will entirely focus on the Renaissance of Psychedelics.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

FEATURED STORIES

Uncategorized3 hours ago

Global Hemp Group Inc (OTCMKTS:GBHPF) Inks A Pact To Takeover Western Sierra Resource Corp (OTCMKTS:WSRC): Becomes A Member Of USHBA

Post Views: 50 Global Hemp Group Inc (OTCMKTS:GBHPF) signed a deal with Prescient Strategies Group LLC to take over all...

CANNABIS SECTOR NEWS3 hours ago

Global Cannabis Applications Corp (OTCMKTS:FUAPF) Enters A Pact With CBD Agrocasa To Apply Efixii QR Codes On CBD Oil Tinctures

Post Views: 51 Global Cannabis Applications Corp (OTCMKTS:FUAPF) signs an MOU (Memorandum of Understanding) with CBD Agrocasa. As per the...

CANNABIS SECTOR NEWS3 hours ago

Heritage Cannabis Holdings Corp (OTCMKTS:HERTF) Ships Derivative Products Under RAD Brand To AGLC And BCLDB For Sale In The Provinces Through Authorized Channels

Post Views: 52 Heritage Cannabis Holdings Corp (OTCMKTS:HERTF) commenced shipping RAD Vapes, RAD Crumble, feelgood topical, RAD CBD Isolate, and...

BIOTECH1 day ago

Tilray Inc (NASDAQ:TLRY) Posts Revenues Of $56.6 Million In Q4 2020: Lowers Annualized Costs By $57 Million YoY

Post Views: 176 Tilray Inc (NASDAQ:TLRY) posts solid growth by strengthening its business in 2020 despite the COVID-19 pandemic. The...

BIOTECH1 day ago

Nutritional High International Inc (OTCMKTS:SPLIF) Posts Drop Of 47.88% In Revenues In 2020

Post Views: 183 Nutritional High International Inc (OTCMKTS:SPLIF) realized cost savings by restructuring its obligations and eliminating unprofitable operations. These...

BIOTECH1 day ago

OrganiGram Holdings Inc (NASDAQ:OGI) Reports A Drop Of 11% In Revenues In Q1 2021: Appoints Marni Wieshofer To The Board Of Directors

Post Views: 161 OrganiGram Holdings Inc (NASDAQ:OGI) posted a decline of 11% in revenues to $25.28 million in Q1 2021....